1. Spinal and bulbar muscular atrophy
17 clinical trials,   16 drugs   (DrugBank: 8 drugs),   10 drug target genes,   15 drug target pathways

Searched query = "Spinal and bulbar muscular atrophy", "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000012503
2014/06/0125/12/2013Effect of creatine in SBMA patients: A double-blind, placebo-controlled clinical study Spinal and Bulbar Muscular AtrophyCreatine monohydrate 10 g, daily for 8 weeks
Creatine monohydrate 15 g, daily for 8 weeks
placebo for 8 weeks
Department of Neurology, Nagoya University Graduate School of MedicineNULLComplete: follow-up continuing20years-old80years-oldMale45Not applicableJapan